Literature DB >> 21782013

Sesquiterpene lactones from Gynoxys verrucosa and their anti-MRSA activity.

Paola E Ordóñez1, Cassandra L Quave, William F Reynolds, Kottayil I Varughese, Brian Berry, Philip J Breen, Omar Malagón, Mark S Smeltzer, Cesar M Compadre.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Because of its virulence and antibiotic resistance, Staphylococcus aureus is a more formidable pathogen now than at any time since the pre-antibiotic era. In an effort to identify and develop novel antimicrobial agents with activity against this pathogen, we have examined Gynoxys verrucosa Wedd (Asteraceae), an herb used in traditional medicine in southern Ecuador for the treatment and healing of wounds.
MATERIALS AND METHODS: The sesquiterpene lactones leucodine (1) and dehydroleucodine (2) were extracted and purified from the aerial parts of Gynoxys verrucosa, and their structure was elucidated by spectroscopic methods and single-crystal X-ray analysis. The in vitro anti-microbial activity of Gynoxys verrucosa extracts and its purified constituents was determined against six clinical isolates including Staphylococcus aureus and Staphylococcus epidermidis strains with different drug-resistance profiles, using the microtiter broth method.
RESULTS: Compound 1 has very low activity, while compound 2 has moderate activity with MIC(50)s between 49 and 195 μg/mL. The extract of Gynoxys verrucosa has weak activity with MIC(50)s between 908 and 3290 μg/mL.
CONCLUSIONS: We are reporting the full assignment of the (1)H NMR and (13)C NMR of both compounds, and the crystal structure of compound 2, for the first time. Moreover, the fact that compound 2 has antimicrobial activity and compound 1 does not, demonstrates that the exocyclic conjugated methylene in the lactone ring is essential for the antimicrobial activity of these sesquiterpene lactones. However, the weak activity observed for the plant extracts, does not explain the use of Gynoxys verrucosa in traditional medicine for the treatment of wounds and skin infections.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782013      PMCID: PMC3159821          DOI: 10.1016/j.jep.2011.07.012

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  13 in total

Review 1.  Anti-staphylococcal plant natural products.

Authors:  Simon Gibbons
Journal:  Nat Prod Rep       Date:  2004-03-01       Impact factor: 13.423

2.  An ethnobotanical survey of medicinal plants used in Loja and Zamora-Chinchipe, Ecuador.

Authors:  Vicente Tene; Omar Malagón; Paola Vita Finzi; Giovanni Vidari; Chabaco Armijos; Tomás Zaragoza
Journal:  J Ethnopharmacol       Date:  2006-11-06       Impact factor: 4.360

Review 3.  Therapeutic challenges in the era of antibiotic resistance.

Authors:  Christopher Lee
Journal:  Int J Antimicrob Agents       Date:  2008-12       Impact factor: 5.283

4.  Sesquiterpene lactones from Achillea collina J. Becker ex Reichenb.

Authors:  Antoaneta Trendafilova; Milka Todorova; Bozhanka Mikhova; Antonina Vitkova; Helmut Duddeck
Journal:  Phytochemistry       Date:  2006-03-13       Impact factor: 4.072

5.  Allergenic sesquiterpene lactones from Eupatorium cannabinum L. and Kaunia rufescens (Lund ex de Candolle).

Authors:  G Rücker; E P Schenkel; D Manns; R Mayer; B M Hausen; K Heiden
Journal:  Nat Toxins       Date:  1997

6.  Antimicrobial activity of Artemisia douglasiana and dehydroleucodine against Helicobacter pylori.

Authors:  A E Vega; G H Wendel; A O M Maria; L Pelzer
Journal:  J Ethnopharmacol       Date:  2009-05-05       Impact factor: 4.360

7.  Fatal brain abscess due to community-associated methicillin-resistant Staphylococcus aureus strain USA300.

Authors:  Costi D Sifri; Jennifer Park; Gregory A Helm; Mary E Stemper; Sanjay K Shukla
Journal:  Clin Infect Dis       Date:  2007-09-21       Impact factor: 9.079

8.  Antidiarrheal activity of dehydroleucodine isolated from Artemisia douglasiana.

Authors:  G H Wendel; A O M María; J A Guzmán; O Giordano; L E Pelzer
Journal:  Fitoterapia       Date:  2007-07-04       Impact factor: 2.882

9.  New cytotoxic sesquiterpene lactones from Warionia saharae.

Authors:  Fatima Hilmi; Otto Sticher; Jörg Heilmann
Journal:  Planta Med       Date:  2003-05       Impact factor: 3.352

10.  Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.

Authors:  Wenming Zhu; Nancye C Clark; Linda K McDougal; Jeffery Hageman; L Clifford McDonald; Jean B Patel
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

View more
  4 in total

Review 1.  Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy.

Authors:  Ashwani Arya; Rubal Chahal; Rekha Rao; Md Habibur Rahman; Deepak Kaushik; Muhammad Furqan Akhtar; Ammara Saleem; Shaden M A Khalifa; Hesham R El-Seedi; Mohamed Kamel; Ghadeer M Albadrani; Mohamed M Abdel-Daim; Vineet Mittal
Journal:  Biomolecules       Date:  2021-02-25

2.  A New Essential Oil from the Leaves of the Endemic Andean Species Gynoxys miniphylla Cuatrec. (Asteraceae): Chemical and Enantioselective Analyses.

Authors:  Omar Malagón; Patricio Cartuche; Angel Montaño; Nixon Cumbicus; Gianluca Gilardoni
Journal:  Plants (Basel)       Date:  2022-01-31

3.  Phytometabolite Dehydroleucodine Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Human Astrocytoma Cells through p73/p53 Regulation.

Authors:  Natalia Bailon-Moscoso; Gabriela González-Arévalo; Gabriela Velásquez-Rojas; Omar Malagon; Giovanni Vidari; Alejandro Zentella-Dehesa; Edward A Ratovitski; Patricia Ostrosky-Wegman
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

Review 4.  The Revaluation of Plant-Derived Terpenes to Fight Antibiotic-Resistant Infections.

Authors:  Floriana Cappiello; Maria Rosa Loffredo; Cristina Del Plato; Silvia Cammarone; Bruno Casciaro; Deborah Quaglio; Maria Luisa Mangoni; Bruno Botta; Francesca Ghirga
Journal:  Antibiotics (Basel)       Date:  2020-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.